Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells

被引:138
作者
Schnurr, M
Toy, T
Shin, A
Hartmann, G
Rothenfusser, S
Soellner, J
Davis, ID
Cebon, J
Maraskovsky, E
机构
[1] Ludwig Inst Canc Res, Oncol Unit, Austin & Repatriat Med Ctr, Melbourne Tumour Biol Branch, Heidelberg, Vic 3084, Australia
[2] Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80539 Munich, Germany
关键词
D O I
10.1182/blood-2003-06-1959
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasmacytoid dendritic cells (PDCs) are potent regulators of immune function and the major source of type I interferon (IFN) following viral infection. PDCs are found at sites of inflammation in allergic reactions, autoimmune disorders, and cancer, but the mechanisms leading to the recruitment of PDCs to these sites remain elusive. During inflammation, adenosine is released and functions as a signaling molecule via adenosine receptors. This study analyzes adenosine receptor expression and function in human PDCs. Adenosine was found to be a potent chemotactic stimulus for immature PDCs via an A(1) receptor-mediated mechanism. The migratory response toward adenosine was comparable to that seen with CXCL12 (stromal-derived factor-1alpha [SIDIP-1alpha), the most potent chemotactic stimulus identified thus far for immature PDCs. Upon maturation, PDCs down-regulate the A, receptor, resulting in a loss of migratory function. In contrast, mature PDCs upregulate the A(2a) receptor, which is positively coupled to adenylyl cyclase and has been implicated in the down-regulation of DC cytokine-producing capacity. We show that in mature PDCs adenosine reduces interleukin-6 (IL-6), IL-12, and IFNI-alpha production in response to CpG oligodeoxynucleotides (ODN). These findings indicate that adenosine may play a dual role in PDC-mediated immunity by initially recruiting immature PDCs to sites of inflammation and by subsequently limiting the extent of the inflammatory response induced by mature PDCs by inhibiting their cytokine-producing capacity.
引用
收藏
页码:1391 / 1397
页数:7
相关论文
共 49 条
[31]   Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes [J].
Link, AA ;
Kino, T ;
Worth, JA ;
McGuire, JL ;
Crane, ML ;
Chrousos, GP ;
Wilder, RL ;
Elenkov, IJ .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :436-442
[32]   Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage [J].
Ohta, A ;
Sitkovsky, M .
NATURE, 2001, 414 (6866) :916-920
[33]   Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells [J].
Panther, E ;
Corinti, S ;
Idzko, M ;
Herouy, Y ;
Napp, M ;
la Sala, A ;
Girolomoni, G ;
Norgauer, J .
BLOOD, 2003, 101 (10) :3985-3990
[34]   Expression and function of adenosine receptors in human dendritic cells [J].
Panther, E ;
Idzko, M ;
Herouy, Y ;
Rheinen, H ;
Gebicke-Haerter, PJ ;
Mrowietz, U ;
Dichmann, S ;
Norgauer, J .
FASEB JOURNAL, 2001, 15 (11) :1963-1970
[35]  
Pedata F, 2001, ANN NY ACAD SCI, V939, P74
[36]   Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells [J].
Penna, G ;
Sozzani, S ;
Adorini, L .
JOURNAL OF IMMUNOLOGY, 2001, 167 (04) :1862-1866
[37]  
Ralevic V, 1998, PHARMACOL REV, V50, P413
[38]   ADENOSINE PROMOTES NEUTROPHIL CHEMOTAXIS [J].
ROSE, FR ;
HIRSCHHORN, R ;
WEISSMANN, G ;
CRONSTEIN, BN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (03) :1186-1194
[39]  
Sajjadi FG, 1996, J IMMUNOL, V156, P3435
[40]   Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions [J].
Salio, M ;
Cella, M ;
Vermi, W ;
Facchetti, F ;
Palmowski, MJ ;
Smith, CL ;
Shepherd, D ;
Colonna, M ;
Cerundolo, V .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (04) :1052-1062